Literature DB >> 7682627

Restricted replication of simian immunodeficiency virus strain 239 in macrophages is determined by env but is not due to restricted entry.

K Mori1, D J Ringler, R C Desrosiers.   

Abstract

Virus derived from the infectious, pathogenic, molecular clone of simian immunodeficiency virus (SIV) called SIVmac239 replicates poorly in primary rhesus monkey alveolar macrophage cultures. Variants with three to nine amino acid changes in the envelope replicate 100 to 1,000 times more efficiently in these macrophage cultures than parental SIVmac239. Early events, including virus entry into cells, were analyzed by measuring the amounts of newly synthesized viral DNA 14 to 16 h after infection of macrophages by using a quantitative polymerase chain reaction method. SIVmac239 ws found to enter macrophages with an efficiency similar to that of the macrophage-tropic derivatives. The assay indeed measured newly synthesized viral DNA since detection was inhibited by the reverse transcriptase inhibitors azidothymidine and foscarnet and by heat inactivation of the virus stock prior to infection. Furthermore, entry of SIVmac239 and macrophage-tropic variant into macrophages was inhibited by monoclonal antibody against CD4. Analysis of the time course of viral DNA accumulation showed that although initial entry of SIVmac239 into cells occurred normally, subsequent logarithmic increases in the amounts of viral DNA associated with spread of virus through the macrophage cultures was blocked. Increasing the amount of SIVmac239 incubated with macrophages increased the amount of virus entering the cell, but this could not overcome the block to replication. Thus, restricted replication of SIVmac239 in macrophages is determined by the envelope, but surprisingly it is not due to restricted virus entry.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7682627      PMCID: PMC237605     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  49 in total

Review 1.  Biology and pathogenesis of lentiviruses.

Authors:  O Narayan; J E Clements
Journal:  J Gen Virol       Date:  1989-07       Impact factor: 3.891

2.  The productive infection of alveolar macrophages by simian immunodeficiency virus.

Authors:  D J Ringler; M S Wyand; D G Walsh; J J MacKey; P K Sehgal; M D Daniel; R C Desrosiers; N W King
Journal:  J Med Primatol       Date:  1989       Impact factor: 0.667

3.  Interleukin-1 and tumor necrosis factor alpha can be induced from mononuclear phagocytes by human immunodeficiency virus type 1 binding to the CD4 receptor.

Authors:  J E Merrill; Y Koyanagi; I S Chen
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

4.  Induction of IL-6 (B cell stimulatory factor-2/IFN-beta 2) production by HIV.

Authors:  K Nakajima; O Martínez-Maza; T Hirano; E C Breen; P G Nishanian; J F Salazar-Gonzalez; J L Fahey; T Kishimoto
Journal:  J Immunol       Date:  1989-01-15       Impact factor: 5.422

5.  Avoiding false positives with PCR.

Authors:  S Kwok; R Higuchi
Journal:  Nature       Date:  1989-05-18       Impact factor: 49.962

6.  Use of eukaryotic expression technology in the functional analysis of cloned genes.

Authors:  B R Cullen
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

Review 7.  Simian immunodeficiency viruses and their relationship to the human immunodeficiency viruses.

Authors:  M B Gardner; P A Luciw
Journal:  AIDS       Date:  1988       Impact factor: 4.177

8.  Characterization of infectious molecular clones of simian immunodeficiency virus (SIVmac) and human immunodeficiency virus type 2: persistent infection of rhesus monkeys with molecularly cloned SIVmac.

Authors:  Y M Naidu; H W Kestler; Y Li; C V Butler; D P Silva; D K Schmidt; C D Troup; P K Sehgal; P Sonigo; M D Daniel
Journal:  J Virol       Date:  1988-12       Impact factor: 5.103

9.  Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B.

Authors:  L Osborn; S Kunkel; G J Nabel
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

10.  Sequence of simian immunodeficiency virus from macaque and its relationship to other human and simian retroviruses.

Authors:  L Chakrabarti; M Guyader; M Alizon; M D Daniel; R C Desrosiers; P Tiollais; P Sonigo
Journal:  Nature       Date:  1987 Aug 6-12       Impact factor: 49.962

View more
  75 in total

1.  Characterization of a late entry event in the replication cycle of human immunodeficiency virus type 2.

Authors:  D J Griffiths; M Dittmar; P Clapham; E Thomas
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

2.  Induction of lymphocyte proliferation and severe gastrointestinal disease in macaques by a nef gene variant SIVmac239.

Authors:  V G Sasseville; Z Du; L V Chalifoux; D R Pauley; H L Young; P K Sehgal; R C Desrosiers; A A Lackner
Journal:  Am J Pathol       Date:  1996-07       Impact factor: 4.307

3.  Determinants of entry cofactor utilization and tropism in a dualtropic human immunodeficiency virus type 1 primary isolate.

Authors:  R J Smyth; Y Yi; A Singh; R G Collman
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

4.  Cell type-specific fusion cofactors determine human immunodeficiency virus type 1 tropism for T-cell lines versus primary macrophages.

Authors:  G Alkhatib; C C Broder; E A Berger
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

5.  Cell tropism of simian immunodeficiency virus in culture is not predictive of in vivo tropism or pathogenesis.

Authors:  Juan T Borda; Xavier Alvarez; Ivanela Kondova; Pyone Aye; Meredith A Simon; Ronald C Desrosiers; Andrew A Lackner
Journal:  Am J Pathol       Date:  2004-12       Impact factor: 4.307

6.  Human immunodeficiency virus type 1 entry into macrophages mediated by macropinocytosis.

Authors:  V Maréchal; M C Prevost; C Petit; E Perret; J M Heard; O Schwartz
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

7.  The "V3" domain is a determinant of simian immunodeficiency virus cell tropism.

Authors:  F Kirchhoff; K Mori; R C Desrosiers
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

8.  The orphan seven-transmembrane receptor apj supports the entry of primary T-cell-line-tropic and dualtropic human immunodeficiency virus type 1.

Authors:  H Choe; M Farzan; M Konkel; K Martin; Y Sun; L Marcon; M Cayabyab; M Berman; M E Dorf; N Gerard; C Gerard; J Sodroski
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

9.  Vaccine protection by a triple deletion mutant of simian immunodeficiency virus.

Authors:  M S Wyand; K H Manson; M Garcia-Moll; D Montefiori; R C Desrosiers
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

10.  Adaptation of the human immunodeficiency virus type 1 envelope glycoproteins to new world monkey receptors.

Authors:  Beatriz Pacheco; Stephane Basmaciogullari; Jason A Labonte; Shi-Hua Xiang; Joseph Sodroski
Journal:  J Virol       Date:  2007-10-24       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.